Literature DB >> 19428144

Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease.

Emily R Rosario1, Lilly Chang, Elizabeth H Head, Frank Z Stanczyk, Christian J Pike.   

Abstract

We examined the relationships between normal aging, Alzheimer's disease (AD), and brain levels of sex steroid hormones in men and women. In postmortem brain tissue from neuropathologically normal, postmenopausal women, we found no age-related changes in brain levels of either androgens or estrogens. In comparing women with and without AD at different ages, brain levels of estrogens and androgens were lower in AD cases aged 80 years and older but not significantly different in the 60-79 year age range. In male brains, we observed that normal aging was associated with significant decreases in androgens but not estrogens. Further, in men aged 60-79 years, brain levels of testosterone but not estrogens were lower in cases with mild neuropathological changes as well as those with advanced AD neuropathology. In male cases over age 80, brain levels hormones did not significantly vary by neuropathological status. To begin investigating the relationships between hormone levels and indices of AD neuropathology, we measured brain levels of soluble β-amyloid (Aβ). In male cases with mild neuropathological changes, we found an inverse relationship between brain levels of testosterone and soluble Aβ. Collectively, these findings demonstrate sex-specific relationships between normal, age-related depletion of androgens and estrogens in men and women, which may be relevant to development of AD.
Copyright © 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428144      PMCID: PMC2930132          DOI: 10.1016/j.neurobiolaging.2009.04.008

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  71 in total

Review 1.  Progression model of prostate cancer.

Authors:  Teresa Acosta Almeida; Nickolas Papadopoulos
Journal:  Methods Mol Biol       Date:  2003

2.  Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

Authors:  Peter P Zandi; Michelle C Carlson; Brenda L Plassman; Kathleen A Welsh-Bohmer; Lawrence S Mayer; David C Steffens; John C S Breitner
Journal:  JAMA       Date:  2002-11-06       Impact factor: 56.272

3.  Increased levels of adrenocortical and gonadal hormones in mild to moderate Alzheimer's disease.

Authors:  Sigbritt Rasmuson; Birgitta Näsman; Kjell Carlström; Tommy Olsson
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

4.  Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats.

Authors:  Csaba Leranth; Ors Petnehazy; Neil J MacLusky
Journal:  J Neurosci       Date:  2003-03-01       Impact factor: 6.167

Review 5.  Neurosteroid metabolism in the human brain.

Authors:  B Stoffel-Wagner
Journal:  Eur J Endocrinol       Date:  2001-12       Impact factor: 6.664

6.  The serum level of free testosterone is reduced in amyotrophic lateral sclerosis.

Authors:  Alessandra Militello; Gaetano Vitello; Christian Lunetta; Antonio Toscano; Gianni Maiorana; Tommaso Piccoli; Vincenzo La Bella
Journal:  J Neurol Sci       Date:  2002-03-15       Impact factor: 3.181

Review 7.  Impact of obesity on hypogonadism in the andropause.

Authors:  R S Tan; S J Pu
Journal:  Int J Androl       Date:  2002-08

8.  Measuring serum oestradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method.

Authors:  Eef Hogervorst; Jonathan Williams; Marc Combrinck; A David Smith
Journal:  Eur J Endocrinol       Date:  2003-01       Impact factor: 6.664

Review 9.  Estrogen and Alzheimer's disease: the story so far.

Authors:  Brenna Cholerton; Carey E Gleason; Laura D Baker; Sanjay Asthana
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 10.  Sex steroids and the construction and conservation of the adult skeleton.

Authors:  B Lawrence Riggs; Sundeep Khosla; L Joseph Melton
Journal:  Endocr Rev       Date:  2002-06       Impact factor: 19.871

View more
  94 in total

1.  Association Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and Glioma.

Authors:  Victoria Zigmont; Amy Garrett; Jin Peng; Michal Seweryn; Grzegorz A Rempala; Randall Harris; Christopher Holloman; Thomas E Gundersen; Anders Ahlbom; Maria Feychting; Tom Borge Johannesen; Tom Kristian Grimsrud; Judith Schwartzbaum
Journal:  Nutr Cancer       Date:  2015-08-28       Impact factor: 2.900

Review 2.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

3.  Brain testosterone deficiency leads to down-regulation of mitochondrial gene expression in rat hippocampus accompanied by a decline in peroxisome proliferator-activated receptor-γ coactivator 1α expression.

Authors:  Takeshi Hioki; Shunya Suzuki; Megumi Morimoto; Tsuneo Masaki; Ryuichi Tozawa; Shigeru Morita; Takashi Horiguchi
Journal:  J Mol Neurosci       Date:  2013-09-05       Impact factor: 3.444

4.  Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell Line.

Authors:  Shaletha Holmes; Meharvan Singh; Chang Su; Rebecca L Cunningham
Journal:  Endocrinology       Date:  2016-05-11       Impact factor: 4.736

Review 5.  Sexual dimorphism in predisposition to Alzheimer's disease.

Authors:  Daniel W Fisher; David A Bennett; Hongxin Dong
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

Review 6.  Alzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactions.

Authors:  Anusha Jayaraman; Christian J Pike
Journal:  Curr Diab Rep       Date:  2014-04       Impact factor: 4.810

7.  Orthotopic Ovarian Transplantation Procedures to Investigate the Life- and Health-span Influence of Ovarian Senescence in Female Mice.

Authors:  Jeffrey B Mason; Kate C Parkinson; Tracy L Habermehl
Journal:  J Vis Exp       Date:  2018-02-12       Impact factor: 1.355

Review 8.  Sex differences in cognitive impairment and Alzheimer's disease.

Authors:  Rena Li; Meharvan Singh
Journal:  Front Neuroendocrinol       Date:  2014-01-13       Impact factor: 8.606

Review 9.  The Potential of Gonadal Hormone Signalling Pathways as Therapeutics for Dementia.

Authors:  X Du; R A Hill
Journal:  J Mol Neurosci       Date:  2016-08-15       Impact factor: 3.444

Review 10.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.